Urgent

NSAID hypersensitivity reaction

Drug reaction · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Reactions to NSAIDs ranging from NSAID-exacerbated respiratory disease (rhinosinusitis/asthma) to urticaria/angioedema and, less commonly, anaphylaxis; many are pharmacological (COX-1 mediated) rather than IgE-mediated and cross-react across NSAIDs.

Red flags

  • Laryngeal oedema / airway compromise
  • Severe bronchospasm
  • Hypotension (anaphylaxis)
  • Reaction to multiple chemically unrelated NSAIDs (cross-reactive phenotype)

Assessment

Differential diagnosis

  • IgE-mediated single-NSAID anaphylaxis
  • Chronic spontaneous urticaria flare
  • ACE-inhibitor angioedema
  • Asthma exacerbation from other trigger

Investigations

  • Detailed drug and reaction history (single agent vs cross-reactive pattern)
  • Assess airway, breathing and circulation acutely
  • Serial tryptase if anaphylaxis suspected
  • Later specialist assessment / supervised drug provocation

Management

  • Stop the NSAID and remove exposure
  • Treat the manifestation: bronchodilators/oxygen for respiratory disease, antihistamines for urticaria/angioedema
  • Treat true anaphylaxis with IM adrenaline
  • Give corticosteroids for significant respiratory or cutaneous involvement
  • Advise avoidance of all COX-1 inhibitors in cross-reactive patients (a selective COX-2 inhibitor may be tolerated under specialist guidance)
  • Refer to allergy/immunology for characterisation

Drugs & doses

Stop the NSAID
Antihistamine for urticaria/angioedema
Bronchodilators and oxygen for respiratory symptoms
IM adrenaline if anaphylaxis
Corticosteroids for significant reactions

Disposition

Discharge after treatment with avoidance advice; allergy referral to characterise and identify safe alternatives.

Complications & pitfalls

  • Anaphylaxis
  • Severe bronchospasm
  • Recurrent reactions with re-exposure

Exam pearls

  • Cross-reactivity across chemically unrelated NSAIDs points to a COX-1 (pharmacological) mechanism rather than true allergy
  • Patients with cross-reactive disease may tolerate a selective COX-2 inhibitor under specialist guidance
  • Aspirin-exacerbated respiratory disease is the classic triad of asthma, nasal polyps and NSAID sensitivity

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.